» Articles » PMID: 19701495

Expression of Zonulin, C-kit, and Glial Fibrillary Acidic Protein in Human Gliomas

Overview
Journal Transl Oncol
Specialty Oncology
Date 2009 Aug 25
PMID 19701495
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The hallmarks of human malignant gliomas are their marked invasiveness and vascularity. Because angiogenesis and tumor invasion have been associated with extracellular matrix degradation and intercellular tight junctions, the involvement of zonulin in glioma biology is in the focus. We selected for histological examination five cases of glioblastoma WHO IV (nomenclature of the World Health Organization) and one case each from astrocytoma WHO III, meningioma WHO III, and meningioma WHO I as control samples. The meningioma WHO I is regarded as benign, whereas the meningioma WHO III is recognized as the transition form of malignant tumors in humans. The visualization of a newly designed antibody against human zonulin was studied in triple-labeling studies using fluorescence immunocytochemistry and compared with the expression of c-kit and glial fibrillary acidic protein in differently developed human gliomas. We found that increasing the expression of c-kit is accompanied by an increase of zonulin expression. Both are correlated to the degree of malignancy of human brain tumors. The expression of zonulin is correlated to the degradation of the blood-brain barrier as revealed by Griffonia simplicifolia lectin. In differently graded tumors, we found differently graded involvement of blood vessels in the tumor development, explaining patients' survival.

Citing Articles

A review of gut failure as a cause and consequence of critical illness.

Soranno D, Coopersmith C, Brinkworth J, Factora F, Muntean J, Mythen M Crit Care. 2025; 29(1):91.

PMID: 40011975 PMC: 11866815. DOI: 10.1186/s13054-025-05309-7.


From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Dora D, Szocs E, Soos A, Halasy V, Somodi C, Mihucz A Front Immunol. 2024; 15:1434804.

PMID: 39301033 PMC: 11410641. DOI: 10.3389/fimmu.2024.1434804.


Zonulin as Gatekeeper in Gut-Brain Axis: Dysregulation in Glioblastoma.

Hagemeyer H, Hellwinkel O, Plata-Bello J Biomedicines. 2024; 12(8).

PMID: 39200114 PMC: 11352073. DOI: 10.3390/biomedicines12081649.


Evaluation of Zonulin Expression and Its Potential Clinical Significance in Glioblastoma.

Repossi R, Martin-Ramirez R, Gomez-Bernal F, Medina L, Farina-Jeronimo H, Gonzalez-Fernandez R Cancers (Basel). 2024; 16(2).

PMID: 38254845 PMC: 10814510. DOI: 10.3390/cancers16020356.


Hemorrhagic transformation in patients with large-artery atherosclerotic stroke is associated with the gut microbiota and lipopolysaccharide.

Huang Q, Wei M, Feng X, Luo Y, Liu Y, Xia J Neural Regen Res. 2023; 19(7):1532-1540.

PMID: 38051896 PMC: 10883505. DOI: 10.4103/1673-5374.385846.


References
1.
Wang W, Uzzau S, Goldblum S, Fasano A . Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000; 113 Pt 24:4435-40. DOI: 10.1242/jcs.113.24.4435. View

2.
Clemente M, De Virgiliis S, Kang J, Macatagney R, Musu M, Di Pierro M . Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut. 2003; 52(2):218-23. PMC: 1774976. DOI: 10.1136/gut.52.2.218. View

3.
Cetin N, Dienel G, Gokden M . CD117 expression in glial tumors. J Neurooncol. 2005; 75(2):195-202. DOI: 10.1007/s11060-005-2318-1. View

4.
Marinaro M, Fasano A, De Magistris M . Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infect Immun. 2003; 71(4):1897-902. PMC: 152047. DOI: 10.1128/IAI.71.4.1897-1902.2003. View

5.
Sihto H, Tynninen O, Butzow R, Saarialho-Kere U, Joensuu H . Endothelial cell KIT expression in human tumours. J Pathol. 2007; 211(4):481-8. DOI: 10.1002/path.2125. View